Latest News

Solace Therapeutics, Inc., announced that data from a multicenter 221 patient randomized controlled trial has met study endpoints with statistical significance. Dr. Eric Rovner will be presenting a poster of the results from the SUCCESS Clinical Trial at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) meeting in Scottsdale, Arizona on Thursday, March, 2nd.

View full press release >

The Vesair Balloon Delivery System has CE mark and is not currently available in the US. It is for investigational use only.

©2017 Solace Therapeutics. All rights reserved.  AV-1015 Rev M • ReferencesPrivacy Policy

Site Design and Development by Conlega Design